Industry Conference

As elder fraud becomes a multi-billion dollar crisis, one fintech is deploying AI to spot victims before they lose everything. A look at the bottom-line impact.

Phase 1 data for Marea Therapeutics’ MAR002 suggests a potential new era for acromegaly treatment, promising better control with far fewer injections.

With over 4.6% of all ETH, Bitmine is not just mining crypto; it's engineering a new kind of financial institution. Is its high-stakes strategy genius or hubris?

As 250 million people await a drug for lymphatic diseases, Celltaxis appoints a new CEO to drive its promising inflammation-targeting therapy toward the finish line.

Trading Technologies partners with ICE to launch a new fixed income EMS, aiming to shatter market silos with a unified multi-asset trading experience.

A new digital marketplace lets dentists bid for your business, promising transparency and lower costs. But can this tech disruption solve the dental affordability crisis?

A partnership born from a military hackathon shows how rapid prototyping is shattering old procurement models and accelerating autonomous defense solutions.

New data reveals an oral drug can halt severe hereditary angioedema attacks in minutes, promising a future free from needles and fear for thousands.

The 18th Straits Forum promotes 'people-to-people' ties, but Taipei calls it a political ploy. What's at stake for the people caught in between?

A forum in Xiamen unveils a RMB 9.1 billion push for financial integration, but is it just about business, or a deeper play for Taiwan's future?

As climate change fuels record dengue outbreaks across Asia, a new six-nation pact aims for 'Zero Deaths.' But can it overcome the gap between innovation and reality?

Independent tests reveal top cybersecurity tools as malware infiltrates trusted platforms. Are you protected from threats hiding in your creative assets?

A new partnership between Argonaut and Ensera aims to untangle complex supply chains for drug-device products, potentially leveling the field for smaller innovators.

The Shanghai Museum dedicates its entire venue to 3,000 artifacts from Mexico and Peru. This isn't just an exhibition; it's a new model for cultural infrastructure.

China's Atom Therapeutics is advancing a dual-threat pipeline, with novel drugs for gout and a groundbreaking anti-inflammatory aimed at cardiovascular disease.

A new pact between BioSTL and the UK's NHS is set to make St. Louis a prime U.S. launchpad for health tech, turning global innovation into local impact.

With new drinks, TaylorMade merch, and John Daly, Dunkin's golf campaign is a lesson in modern branding. It's about selling an identity, not just a product.

Beyond the pitch, Hisense's role as FIFA's VAR provider is a masterstroke, leveraging high-stakes officiating to cement its dominance in the big-screen TV market.

With the 2026 World Cup looming, Men in Blazers partners with NFQ Technologies to build a central digital hub, aiming to turn fleeting attention into lasting loyalty.

Beyond headlines of chip wars, a 30-year partnership between Taiwan's ITRI and Europe is quietly building our future in AI, green energy, and robotics.